Complete report $1,850. DataPack (test volumes, sales forecasts, supplier shares) $450. Summary This report presents a detailed analysis of the US AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Physician Offices
- Public Health Laboratories In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, Ortho Clinical Diagnostics, Novartis, and Roche. Highlights Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses. Examines market applications of Molecular Diagnostics, Immundiagnostics, IT and other emerging technologies. Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers. Profiles over 30 leading manufacturers and potential market entrants developing innovative technologies and products. Analyzes alternative market penetration strategies for suppliers.
Methodology The report is based on a combination of primary and secondary information sources, including Venture Planning Group’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Contains 251 pages and 7 tables
|